Posted by Michael Wonder on 19 Dec 2018
NICE appraisal fees to be introduced despite opposition
14 December 2018 - Concessions made for small companies.
England’s cost effectiveness watchdog NICE is to start charging pharmaceutical companies for appraisals of their drugs from April 2019, despite considerable resistance from the industry and other stakeholders.
The fee for single technology appraisals and highly specialised technology appraisals will be £126,000 ($158,500, €140,400).
